Coordinated regulation of β-tubulin isotypes and epithelial-to- mesenchymal transition protein ZEB1 in breast cancer cells

Biochemistry

Volumn 52, Issue 32, 2013, Pages 5482-5490

  Lobert, Sharon ^a   Graichen, Mary E ^a   Morris, Kevin ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER CELLS; CHEMOTHERAPEUTIC DRUGS; FEEDBACK REGULATION; MDA-MB-231 CELLS; OVARIAN CANCERS; TRIPLE-NEGATIVE BREAST CANCERS; TUMOR PROGRESSIONS; TUMOR SUPPRESSORS;

CELL CULTURE; CELLS; DISEASES; GENES; TUMORS;

NUCLEIC ACIDS;

BETA TUBULIN; MICRORNA 200C; PACLITAXEL; TRANSCRIPTION FACTOR ZEB1;

ARTICLE; CANCER CELL; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; PACLITAXEL; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUBULIN; UP-REGULATION;

EID: 84881638209     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi400340g     Document Type: Article

References (24)

1. Cochrane (2009) Mol. Cancer Ther. 8 (5), 1055-1066
2. Cittelly, D.M. (2012) Mol. Cancer Ther. 11 (12), 2556-2565
3. Esquela-Kerscher, A. and Slack, F. J. (2006) Oncomirs-microRNAs with a Role in Cancer Nat. Rev. Cancer. 6, 259-269
4. Heneghan, H. M., Miller, N., and Kerin, M. J. (2010) MiRNAs As Biomarkers and Therapeutic Targets in Cancer Curr. Opin. Pharmacol. 10, 543-550
5. Yu, Z., Baserga, R., Chen, L., Wang, C., Lisanti, M. P., and Pestell, R. G. (2010) MicroRNA, Cell Cycle and Human Breast Cancer Am. J. Pathol. 176 (3) 1058-1064
6. Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Nordeen, S. K., and Richer, J. K. (2009) MicroRNA-200c Mitigates Invasiveness and Restores Sensitivity to Microtubule-Targeting Chemotherapeutic Agents Mol. Cancer Ther. 8 (5) 1055-1066
7. Leskelä, S., Liandro-Garcia, L. J., Mendiola, M., Barriuso, J., Inglada-Perez, L., Munoz, I., Martinez-Delgado, B., Redondo, A., de Santiago, J., Robledo, M., Hardisson, D., and Rodriquez-Antona, C. (2011) The miR-200 Family Controls β-Tubulin III Expression and Is Associated Wth Paclitaxel-Based Treatment Response and Progression-Free Survival in Ovarian Cancer Patients Endocr.-Relat. Cancer 11, 85-92
8. Kamath, K., Wilson, L., Cabral, F., and Jordan, M. A. (2005) βIII-Tubulin Induces Paclitaxel Resistance in Association with Reduced Effects on Microtubule Dynamic Instability J. Biol. Chem. 280 (13) 12902-12907
9. Cittelly, D. M., Dimitrova, O., Howe, E. N., Cochrane, D. R., Jean, A., Spoelstra, N. S., Post, M. D., Lu, X., Broaddus, R. R., Spillman, M. A., and Richer, J. K. (2012) Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel Mol. Cancer Ther. 11 (12) 2556-2565
10. Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., and Brabletz, T. (2008) A Reciprocal Repression Obetween ZEB1 and Members of the miR-200 Family Promotes EMT and Invasion in Cancer Cells EMBO Rep. 9 (6) 582-589
11. Vanderwalle, C., Van Roy, F., and Berx, G. (2009) The Role of ZEB Family Transcription Factors in Development and Disease Cell. Mol. Life Sci. 66, 773-787
12. Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., and Schreiber, M. 2007, The Transcription Factor ZEB1 (δEF1) Promotes Tumour Cell Dedifferentiation by Repressing Master Regulators of Epithelial Polarity Oncogene 26, 6979-6988
13. De Donato, M., Mariani, M., Petrella, L., Martinelli, E., Zannoni, G. F., Vellone, V., Gerrandina, G., Shahabi, S., Scambia, G., and Ferlini, C. (2011) Class III β-Tubulin and the Cytoskeletal Gateway for Drug Resistance in Ovarian Cancer J. Cell Physiol. 227, 1034-1041
14. Lobert, S., Hiser, L., and Correia, J. J. (2010) in Microtubules, In Vitro (Correia, J. J. and Wilson, L., Eds.) Methods in Cell Biology series, Vol. 95, pp 47-58, Elsevier: Burlington, MA.
15. Hiser, L., Aggarwal, A., Young, R., Spano, A., Frankfurter, A., Correia, J. J., and Lobert, S. (2006) Comparison of β-Tubulin mRNA and Protein Levels in Twelve Human Cancer Cell Lines Cell Motil. Cytoskeleton 63, 41-52
16. Lobert, S., Jefferson, B., and Morris, K. (2011) Regulation of β-Tubulin Iostypes by Micro-RNA 100 in MCF7 Breast Cancer Cells Cytoskeleton 68, 355-362
17. Graham, T. R., Yacoub, R., Taliaferro-Smith, L., Osunkoya, A. O., Odero-Marah, V. A., Liu, T., Kimbro, K. S., Sharma, D., and O'Regan, R. M. (2010) Reciprocal Regulation of ZEB1 and AR in Triple Negative Breast Cancer Cells Breast Cancer Res. Treat. 123, 139-147
18. Caron, J. M., Jones, A. L., and Kirschner, M. W. (1985) Autoregulation of Tubulin Synthesis in Hepatocytes and Fibroblasts J. Cell Biol. 101, 1763-1772
19. Pachter, J. S., Yen, T. J., and Cleveland, D. W. (1987) Autoregulation of Tubulin Expression Is Achieved through Specific Degradation of Polysomal Tubulin mRNAs Cell 51, 283-292
20. Theodorakis, N. G. and Cleveland, D. W. (1992) Physical Evidence for Cotranslational Regulation of β-Tubulin mRNA Degradation Mol. Cell. Biol. 12 (2) 7 91-799
21. Yen, T. J., Gay, D. A., Pachter, J. S., and Cleveland, D. W. (1988) Autoregulated Changes in Stability of Polyribosome-Bound β-Tubulin mRNAs Are Specified by the First 13 Translated Nucleotides Mol. Cell. Biol. 8 (3) 1224-1235
22. Ferlini, C., Raspaglio, G., Cicchillitti, L., Mozzetti, S., Prislei, S., Bartollino, S., and Scambia, G. (2007) Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work? Curr. Cancer Drug Targets 7 (8) 704-712
23. Cheng, C., Xuping, F., Alves, P., and Gertein, M. (2009) mRNA Expression Profiles Show Differential Regulatory Effects of microRNAs between Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancer Genome Biol. 10, 90 10.1186/gb-2009-10-9-r90
24. Darshan, M. S., Loftus, M. S., Thadani-Mulero, M., Levy, B. P., Escuin, D., Zhou, X. K., Gjyrezi, A., Chanel-Vos, C., Shen, R., Tagawa, S. T., Bander, N. H., Nanus, D. M., and Giannakakou, P. (2011) Taxane-Induced Blockage to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer Cancer Res. 71 (18) 6019-6029